In 2024, NRT smoking cessation aids is set to experience low positive retail current value growth in the US. While no category is expected to achieve significant success, NRT gum is the only one projected to report positive current value growth, with NRT lozenges and patches set to decline. Notably, NRT patches is expected to see solid declines in current value terms over the forecast period, as these products are struggling to compete with the growing popularity of newer, more convenient oral a...
Euromonitor International's NRT Smoking Cessation Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the NRT Smoking Cessation Aids market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
NRT Smoking Cessation Aids in the US
Euromonitor International
September 2024
List Of Contents And Tables
NRT SMOKING CESSATION AIDS IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Patch format continues to witness a stagnant performance
Haleon’s international divestments hint at uncertain trajectory for the domestic landscape